Get the Stockscreener App
1.545
0.32%
-0.005
Biote Corp stock is traded at $1.545, with a volume of 77,384.
It is down -0.32% in the last 24 hours and down -31.94% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
77,384
Relative Volume:
0.26
Market Cap:
$44.31M
Revenue:
$188.16M
Net Income/Loss:
$18.43M
P/E Ratio:
3.4333
EPS:
0.45
Net Cash Flow:
$26.45M
1W Performance:
-1.59%
1M Performance:
-31.94%
6M Performance:
-26.78%
1Y Performance:
-54.42%
1-Day Range:
$1.515
$1.60
1-Week Range:
$1.51
$1.80
52-Week Range:
$1.27
$3.575
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
5.00 | 394.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.15 | 315.90M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.39 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
120.75 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
Tranche Update on biote Corp.'s Equity Buyback Plan announced on January 25, 2024. - marketscreener.com
Biote Corp. Earnings Call: Recovery Amid Recall Headwinds - TipRanks
Biote (BTMD) Q2 2026 Earnings Call Transcript - AOL.com
Biote Corp. executive chairman Marc Beer buys over $202k in shares - Investing.com
Haymaker Acquisition Corp. IIIClass A common stock (NQ: HYAC - FinancialContent
Marc Beer Bought 122% More Shares In biote - simplywall.st
Insider Buying: biote (NASDAQ:BTMD) Chairman Purchases $177,403.50 in Stock - MarketBeat
biote Corp. Q2 2026: Revenue $44.23M, EPS $(0.23) — 10-Q Summary - TradingView
biote Corp (NASDAQ: BTMD) swings to Q2 2026 loss as costs rise - Stock Titan
Biote Corp (BTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biote Corp (BTMD) Stock News Today - TradingKey
Tranche Update on biote Corp.'s Equity Buyback Plan announced on June 20, 2024. - marketscreener.com
Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ... - Yahoo Finance
biote Corp earnings missed by $0.25, revenue fell short of estimates - Investing.com
biote Corp. (BTMD) Reports Break-Even Earnings for Q2 - Yahoo Finance
Earnings call transcript: Biote Q2 2026 revenue miss weighs on shares - Investing.com
biote Q2 Earnings Call Highlights - MarketBeat
BTMD: Revenue fell 9.5% in Q2 2026, with revised full-year guidance and improving supply outlook - TradingView
biote (NASDAQ:BTMD) Posts Quarterly Earnings Results, Misses Estimates By $0.26 EPS - MarketBeat
biote Corp. (BTMD) Releases Q2 2026 Earnings: Revenue Declines and EPS Miss - Quiver Quantitative
biote Reports Q2 2026: Revenue $44.2M, Adjusted EBITDA $5.6M, Revises Full‑Year Outlook - TradingView
Biote Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Voluntary recall delays Biote’s return to procedure-revenue growth - Stock Titan
Earnings To Watch: Biote Corp (BTMD) Q2 2026 -- GF Value Sees 39% Upside - GuruFocus
Biote Corp (BTMD) Sheds 0.87% as Shares Test Key Support at $2.16Dark Pool Sentiment - dars.gov.et
Biote Corp expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Biote Corp. (BTMD) Rallies 2.5% as Stock Tests Key Resistance Near $2.40Supply Zone - dars.gov.et
BlackRock (BTMD holder) discloses 359,732 Biote Corp shares in 13G/A filing - Stock Titan
Biote Corp (BTMD) Balance Sheet - TradingKey
Biote Corp (BTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biote Corp (BTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biote Corp (BTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biote Corp (BTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biote Corp (BTMD) Income Statement - TradingKey
Biote Corp (BTMD) Cash Flow - TradingKey
Biote Corp (BTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BTMD|Biote Corp|Price:1.480|Chg%:+0.120 - TradingKey
BTMD|Biote Corp|Price:2.320|Chg%:+0.040 - TradingKey
Biote Corp (BTMD) Institutional Confidence - TradingKey
Biote Corp (BTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
BTMD|Biote Corp|Price:1.380|Chg%:+0.080 - TradingKey
BTMD Q1 2026 Earnings: EPS Beats Estimates Amid Quiet Trading SessionManagement Tone Analysis - vinanet.vn
Biote to announce Q2 2026 financial results on August 5 - scanx.trade
Press Release: Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call - Moomoo
Biote’s Q2 results call is set for 5 p.m. ET on Aug. 5 - Stock Titan
BTMD Q1 2026 Earnings: EPS Beats Estimates by 23.71% as Stock Declines 6.75%EPS Estimate Trend - Vinanet
biote (BTMD) Proxy Filing Summary - Quartr
biote (BTMD) Q4 2024 earnings summary - Quartr
BTMD Q1 2026 Earnings: EPS Beats Estimates by Over 23%, Shares SurgeGuidance Downgrade Alert - vinanet.vn
5 Best Biotech Stocks for 2026 and How to Invest - The Motley Fool
Biote Corp. (BTMD) Posts Modest Advance, Holds Above Key Support LevelStop Loss Guidance - dars.gov.et
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biote Corp Stock (BTMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Beer Marc D | Executive Chairman |
Aug 11 '26 |
Buy |
1.55 |
16,000 |
24,800 |
239,744 |
0.78%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):